Recruiting Kidney Cancer Studies in Duarte
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immun...
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
The purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib in adult patients with confirmed advanced o...
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherap...
Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
This phase II trial compares the effect of atezolizumab in combination with usual treatment with cabozantinib to cabozantinib alone in patients with papillary renal cell carcinoma that has spread from...
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
This phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell renal cell (kidney) cancer that has spread to...
About Kidney Cancer Clinical Trials in Duarte
Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.
There are currently 5 kidney cancer clinical trials recruiting participants in Duarte, CALIFORNIA. These studies are seeking a combined 2,254 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Arcus Biosciences, Inc., NRG Oncology and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Kidney Cancer Clinical Trials in Duarte — FAQ
Are there kidney cancer clinical trials in Duarte?
Yes, there are 5 kidney cancer clinical trials currently recruiting in Duarte, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Duarte?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.
Are clinical trials in Duarte free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.
What kidney cancer treatments are being tested?
The 5 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.
Data updated March 2, 2026 from ClinicalTrials.gov